Chengxin Gu
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Berberine enhances the anti-hepatocellular carcinoma effect of NK92-MI cells through inhibiting IFN-gamma-mediated PD-L1 expression.
Journal: Liver research (Beijing, China)
Published: March 20, 2022
Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs.
Berberine Sensitizes Human Hepatoma Cells to Regorafenib via Modulating Expression of Circular RNAs.
Journal: Frontiers in pharmacology
Published: November 22, 2020
Caffeine enhances the anti-tumor effect of 5-fluorouracil via increasing the production of reactive oxygen species in hepatocellular carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: July 23, 2019
Berberine Inhibits Nod-Like Receptor Family Pyrin Domain Containing 3 Inflammasome Activation and Pyroptosis in Nonalcoholic Steatohepatitis via the ROS/TXNIP Axis.
Journal: Frontiers in pharmacology
Published: July 09, 2019
Berberine, a natural plant alkaloid, synergistically sensitizes human liver cancer cells to sorafenib.
Journal: Oncology reports
Published: January 11, 2018
LncRNA-AK012226 Is Involved in Fat Accumulation in db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model.
Journal: Frontiers in pharmacology
Published: December 12, 2017
LncRNA-uc002mbe.2 Interacting with hnRNPA2B1 Mediates AKT Deactivation and p21 Up-Regulation Induced by Trichostatin in Liver Cancer Cells.
Journal: Frontiers in pharmacology
Published: July 12, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026